Show Notes
Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing efforts have moved from the super rich to a mass market consumer industry. In this series, we’re covering the past, present and future of the longevity movement. We’ll be looking at where the fixation on longevity is coming from, and trying to understand the practical and ethical issues at the heart of this cutting-edge field of research.
From Silicon Valley fantasies, to Singaporean health spas, to Colombian genetic clinics and beyond, the FT’s Hannah Kuchler and Michael Peel ask whether breakthroughs in science and technology can really help us live longer, and even stop us aging altogether.
Free to read:
US ‘wellness’ industry scents opportunity to go mainstream
The quest to make young blood into a drug
This season of Tech Tonic was produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio.
The FT does not use generative AI to voice its podcasts.
Hosted on Acast. See acast.com/privacy for more information.
More from FT Tech Tonic
Could AI help us understand ourselves and each other better? Writer and philosopher Alain de Botton speaks to the FT’s Madhumita Murgia about the challenges we face navigating human relationships, and how AI might be able to help. Recorded live at the FT Weekend Festival.
Murad Ahmed speaks to FT journalist Sarah O’Connor about her new book ‘We Are Not Machines’, which explores the impact AI is already having on workplaces. They discuss how Swedish miners dealt with the introduction of AI-powered vehicles, and how Czech translators found AI stealing the most creative part of their job. Recorded live at the FT Weekend Festival.
AI-related investments are now worth up to half of the entire value of the S&P 500. But is the AI investment boom a bubble waiting to burst? Tim Bradshaw, the FT’s global technology correspondent, speaks to Richard Kramer, founder of Arete Research, and Ophelia Brown, founder of Blossom Capital. Recorded live at the FT Weekend Festival on 5th September 2026.
At the Enhanced Games in Las Vegas earlier this year, athletes used performance-enhancing drugs and banned equipment in an attempt to break world records. At the same time, companies such as Adidas are designing new types of equipment that fall within the rules, but give athletes an edge. So where is the line between cheating and innovation?
Video-assistant refereeing (VAR) has proved to be one of the most controversial pieces of technology ever introduced in sports. But with the rise of everything from broadcasting gimmicks to data-driven gambling, it’s far from the only technology changing what it means to be a fan. The FT’s sports editor Josh Noble asks whether these advancements are making sport more fun to watch, or overshadowing the event itself.